NYSEARCA:KEM - NYSE Arca - US5007674394 - ETF - Currency: USD
Zynex (NASDAQ:ZYXI) is up 9.1% after hours following news that it's moving into the S&P SmallCap 600 index. It's replacing KEMET (NYSE:KEM) in the index, with Yageo Corp. close to closing its dea
Mentions: ZYXI
Kemet (NYSE:KEM) received the final approvals for its pending Yageo acquisition and the parties expect to close the merger on or about June 15, 2020.On closure, Yageo will acquire all outstanding shar
Shares of Kemet (NYSE:KEM) remained unaffected at $27.03 after the company reported Q4 results. Quarterly Results Earnings per share decreased 64.76% over the past year to $0.37,...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) AbbVie Inc (NYSE: ABBV) -...
Today, a Director at Kemet (KEM – Research Report), Robert G. Paul, sold shares of KEM for $156.4K. Following Robert G. Paul’s last KEM Sell transaction on February 07, 2019, the stock climbed by 8.7%. See today’s analyst top recommended stocks >> The company has a one-year high of $27.61 and a one-year low of
KEM earnings call for the period ending March 31, 2020.
Kemet (KEM) delivered earnings and revenue surprises of 105.56% and 15.83%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Kemet (NYSE:KEM): Q4 Non-GAAP EPS of $0.37 beats by $0.20; GAAP EPS of $0.01 misses by $0.13.Revenue of $293.2M (-17.6% Y/Y) beats by $40.1M.Press Release
AG, AZUL, BAM, GDS, KEM, MDP, MLCO, NCLH, NICE, NVMI, SPNS, SSYS, WIX, WNCFor Seeking Alpha's full earnings season calendar, click here.
Kemet (KEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kemet (NYSE:KEM) +3.6% pre-market after announcing the completion of the CFIUS review of the company's pending acquisition by Yageo (OTCPK:YGEQF).The company says the review found no unresolved nation
Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on Kemet (KEM – Research Report), Turtle Beach (HEAR – Research Report) and Semtech (SMTC – Research Report). Kemet (KEM) B.Riley FBR analyst Craig Ellis reiterated a Hold rating on Kemet yesterday and set a price target of
Kemet (NYSE:KEM) announces that proxy advisor Institutional Shareholder Services recommends that shareholders vote in favor of the all-cash acquisition by Yageo.ISS: "Support for the merger is war
KEM earnings call for the period ending December 31, 2019.
Kemet (KEM) delivered earnings and revenue surprises of 27.78% and 0.79%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Kemet (NYSE:KEM): Q3 Non-GAAP EPS of $0.46 beats by $0.10; GAAP EPS of $0.28 in-line.Revenue of $294.74M (-15.8% Y/Y) beats by $2.31M.Press Release
ABMD, AGCO, ALNY, ARCH, ARW, BCE, BCO, BDX, BGCP, BLL, BMY, BV, CAH, CDW, CI, COR, DNKN, EAF, EIGI, EL, FCAU, GLOP, HAIN, HL, ICE, K, KEM, MAC, MDP, MMS, MPW, MT, NGL, NJR, NRZ, NYT, ODFL, PBH, PENN,
Kemet (KEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here is a sneak peek into how four electronics stocks might fare in their quarterly results, slated to release on Jan 30.